Pharmacology of 5-Aza-2'-deoxycytidine (decitabine)MOMPARLER, Richard L.Seminars in hematology. 2005, Vol 42, Num 3, pp S9-S16, issn 0037-1963, SUP2Article

Decitabine dosing schedulesKANTARJIAN, Hagop M; ISSA, Jean-Pierre J.Seminars in hematology. 2005, Vol 42, Num 3, pp S17-S22, issn 0037-1963, SUP2Article

Issues regarding study design for initial clinical trials using decitabineDEBAUN, Michael R.Seminars in hematology. 2004, Vol 41, Num 4, pp 23-27, issn 0037-1963, 5 p., SUP6Conference Paper

Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine)MOMPARLER, Richard L.Seminars in oncology. 2005, Vol 32, Num 5, pp 443-451, issn 0093-7754, 9 p.Article

Decitabine in myelodysplastic syndromesSABA, Hussain I; WIJERMANS, Pierre W.Seminars in hematology. 2005, Vol 42, Num 3, pp S23-S31, issn 0037-1963, SUP2Article

Clinical development of decitabine as a prototype for an epigenetic drug programROSENFELD, Craig S.Seminars in oncology. 2005, Vol 32, Num 5, pp 465-472, issn 0093-7754, 8 p.Article

Decitabine in chronic leukemiasISSA, Jean-Pierre J; BYRD, John C.Seminars in hematology. 2005, Vol 42, Num 3, pp S43-S49, issn 0037-1963, SUP2Article

Transcriptional reactivation of murine cytomegalovirus ie gene expression by 5-aza-2'-deoxycytidine and trichostatin A in latently infected cells despite lack of methylation of the major immediate-early promoterHUMMEL, Mary; SHIXIAN YAN; ZHIGAO LI et al.Journal of general virology. 2007, Vol 88, pp 1097-1102, issn 0022-1317, 6 p., 4Article

Inhibition of methylation decreases osteoblast differentiation via a non-DNA-dependent methylation mechanismVAES, Bart L. T; LUTE, Carolien; VAN DER WONING, Sebastian P et al.Bone (New York, NY). 2010, Vol 46, Num 2, pp 514-523, issn 8756-3282, 10 p.Article

Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabineLAVELLE, Donald; VAITKUS, Kestis; COVEY, Joseph et al.Blood. 2012, Vol 119, Num 5, pp 1240-1247, issn 0006-4971, 8 p.Article

DNA methylation changes after 5-Aza-2'-deoxycytidine therapy in patients with leukemiaYANG, Allen S; DOSHI, Ketan D; KANTARJIAN, Hagop M et al.Cancer research (Baltimore). 2006, Vol 66, Num 10, pp 5495-5503, issn 0008-5472, 9 p.Article

Characterization of dna demethylation effects induced by 5-Aza-2'-deoxycytidine in patients with myelodysplastic syndromeMUND, Cora; HACKANSON, Björn; STRESEMANN, Carlo et al.Cancer research (Baltimore). 2005, Vol 65, Num 16, pp 7086-7090, issn 0008-5472, 5 p.Article

Evaluation of a 7-day continuous intravenous infusion of decitabine: Inhibition of promoter-specific and global genomic DNA methylationSAMLOWSKI, Wolfram E; LEACHMAN, Sancy A; KARPF, Adam R et al.Journal of clinical oncology. 2005, Vol 23, Num 17, pp 3897-3905, issn 0732-183X, 9 p.Article

Decitabine in acute myeloid leukemiaLÜBBERT, Michael; MINDEN, Mark.Seminars in hematology. 2005, Vol 42, Num 3, pp S38-S42, issn 0037-1963, SUP2Article

A randomised, phase II trial of the DNA-hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in combination with carboplatin vs carboplatin alone in patients with recurrent, partially platinum-sensitive ovarian cancerGLASSPOOL, R. M; BROWN, R; GABRA, H et al.British journal of cancer. 2014, Vol 110, Num 8, pp 1923-1929, issn 0007-0920, 7 p.Article

Update on the pharmacotherapy for myelodysplastic syndromesDUONG, Vu H; KOMROKJI, Rami S; LIST, Alan F et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 13, pp 1811-1825, issn 1465-6566, 15 p.Article

Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adultsPHILLIPS, Christine L; DAVIES, Stella M; BLUM, William et al.British journal of haematology. 2013, Vol 161, Num 3, pp 406-410, issn 0007-1048, 5 p.Article

DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemiaMETZELER, K. H; WALKER, A; GEYER, S et al.Leukemia. 2012, Vol 26, Num 5, pp 1106-1107, issn 0887-6924, 2 p.Article

Histiocytoid Sweet's syndrome potentially related to decitabine in a patient with myelodysplastic syndromePARK, Ji-Youn; PARK, Joon Seong; KIM, You Chan et al.EJD. European journal of dermatology. 2012, Vol 22, Num 6, pp 811-812, issn 1167-1122, 2 p.Article

Clofarabine Plus Low-Dose Cytarabine Followed by Clofarabine Plus Low-Dose Cytarabine Alternating With Decitabine in Acute Myeloid Leukemia Frontline Therapy for Older PatientsFADERL, Stefan; RAVANDI, Farhad; BURGER, Jan et al.Cancer. 2012, Vol 118, Num 18, pp 4471-4477, issn 0008-543X, 7 p.Article

Decitabine, a DNA methyltransferase inhibitor, induces apoptosis in human leukemia cells through intracellular reactive oxygen species generationDONG YEOK SHIN; PARK, You-Soo; YANG, Kwangmo et al.International journal of oncology. 2012, Vol 41, Num 3, pp 910-918, issn 1019-6439, 9 p.Article

Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemiaYAN, Pearily; FRANKHOUSER, David; METZELER, Klaus et al.Blood. 2012, Vol 120, Num 12, pp 2466-2474, issn 0006-4971, 9 p.Article

Brief report A pilot study of subcutaneous decitabine in β-thalassemia intermediaOLIVIERI, Nancy F; SAUNTHARARAJAH, Yogen; THAYALASUTHAN, Vivek et al.Blood. 2011, Vol 118, Num 10, pp 2708-2711, issn 0006-4971, 4 p.Article

Changes in the levels of DNA methylation in testis and liver of SD rats neonatally exposed to 5-aza-2'-deoxycytidine and cadmiumHONGYAN ZHU; KEYONG LI; JIREN LIANG et al.JAT. Journal of applied toxicology. 2011, Vol 31, Num 5, pp 484-495, issn 0260-437X, 12 p.Article

Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's LymphomasSTATHIS, Anastasios; HOTTE, Sebastien J; WANG, Lisa et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1582-1590, issn 1078-0432, 9 p.Article